ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice

详细信息    查看全文

• 作者：Emanuela Signori ; Monica Rinaldi ; Daniela Fioretti ; S ; ra Iurescia ; Davide Seripa ; Giuseppe Perrone ; Giuseppe Danilo Norata ; Alberico Luigi Catapano ; Vito Michele Fazio
• 关键词：Plasmid vector ; ApolipoproteinE ; Neonatal gene therapy ; Hypercholesterolemia ; Intramuscular gene transfer
• 刊名：Biochemical and Biophysical Research Communications
• 出版年：2007
• 出版时间：21 September 2007
• 年：2007
• 卷：361
• 期：2
• 页码：543-548
• 全文大小：462 K

文摘

Apolipoprotein E, a key regulator in cholesterol-rich lipoprotein metabolism, is considered a strong candidate for treating hypercholesterolemia and cardiovascular disease. Inherited deficiency of this protein results in type III hyperlipoproteinemia in humans. ApoE-knockout mice, which develop spontaneous hypercholesterolemia, are an excellent model of human atherosclerosis. Here we investigated the therapeutic effects of a plasmid vector encoding human APOE3 sequence intramuscularly injected in hypercholesterolemic newborn mice at the ages of 5 and 14 days. We further explored the possibility of inducing tolerance in newborns when injected early. Our data show that direct i.m. naked DNA injection reduces severe hypercholesterolemia in newborn mice. Moreover, when naked DNA is administrated early, no immune response is generated against the human APOE, allowing repeated administrations. Neonatal therapies are important for the treatment of many genetic childhood diseases where early administration is required to prevent developmental damage. We propose the use of direct i.m. naked gene transfer in newborns to prevent long-term damages arising from hypercholesterolemic conditions.